Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 2
Submit an article Journal homepage
620
Views
11
CrossRef citations to date
0
Altmetric
Review Article

Genomic stratification of multiple myeloma treated with novel agents

Allan JiangDepartment of Laboratory Hematology and Medical Oncology, University Health Network, Toronto, Canada
,
Donna ReeceDepartment of Laboratory Hematology and Medical Oncology, University Health Network, Toronto, Canada
&
Hong ChangDepartment of Laboratory Hematology and Medical Oncology, University Health Network, Toronto, CanadaCorrespondence[email protected]
Pages 202-207 | Received 03 Jun 2011, Accepted 21 Jul 2011, Published online: 19 Sep 2011

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Anne-Marie Ronchetti, Françoise Isnard, Marc Buffet, Tereza Coman, Norbert-Claude Gorin, Paul Coppo, Laurent Garderet & Sandra Malak. (2013) Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents. Leukemia & Lymphoma 54:5, pages 1117-1119.
Read now

Articles from other publishers (10)

Jing Yuan, Li Xu, Hai-Juan Bao, Jie-lin Wang, Yang Zhao & Shuo Chen. (2023) Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Jizhe Liu, Fei Wang, Yindan Zhang, Jingfeng Liu & Bixing Zhao. (2022) ADAR1-Mediated RNA Editing and Its Role in Cancer. Frontiers in Cell and Developmental Biology 10.
Crossref
Phaik Ju Teoh, Omer An, Tae-Hoon ChungJing Yuan ChooiSabrina H. M. TohShuangyi FanWilson WangBryan T. H. Koh, Melissa J. Fullwood, Melissa G. Ooi, Sanjay de Mel, Cinnie Y. Soekojo, Leilei Chen, Siok Bian Ng, Henry YangWee Joo Chng. (2018) Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood 132:12, pages 1304-1317.
Crossref
Michelle Dolan. 2016. Plasma Cell Neoplasms. Plasma Cell Neoplasms 79 99 .
Jess F. Peterson, Nidhi Aggarwal, Clayton A. Smith, Susanne M. Gollin, Urvashi Surti, Aleksandar Rajkovic, Steven H. Swerdlow & Svetlana A. Yatsenko. (2015) Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?. Oncotarget 6:22, pages 18845-18862.
Crossref
Chun Cao, Ting Liu, Huanling Zhu, Lin Wang, Shen Kai & Bing Xiang. (2014) Bortezomib-Contained Chemotherapy and Thalidomide Combined With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) Play Promising Roles in Plasmablastic Lymphoma: A Case Report and Literature Review. Clinical Lymphoma Myeloma and Leukemia 14:5, pages e145-e150.
Crossref
Lenka Pavlistova, Zuzana Zemanova, Iveta Sarova, Halka Lhotska, Adela Berkova, Ivan Spicka & Kyra Michalova. (2014) Change in ploidy status from hyperdiploid to near-tetraploid in multiple myeloma associated with bortezomib/lenalidomide resistance. Cancer Genetics 207:7-8, pages 326-331.
Crossref
Jahangir Abdi, Guoan Chen & Hong Chang. (2013) Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms. Oncotarget 4:12, pages 2186-2207.
Crossref
Mohammad Bahmanyar, Xiaoying Qi & Hong Chang. (2013) Genomic aberrations in anaplastic multiple myeloma: High frequency of 1q21(CKS1B) amplifications. Leukemia Research 37:12, pages 1726-1728.
Crossref
Manujendra N. Saha, Hua Jiang, Yijun Yang, Donna Reece & Hong Chang. (2013) PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa. Molecular Cancer Therapeutics 12:11, pages 2331-2341.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.